瑞芬太尼较硝酸甘油更增强脑组织缺氧耐受性

2012-04-14 张辉摘编 医学论坛网

  南昌大学第一附属医院张学康、曾而明等发表的一项研究表明,瑞芬太尼控制性降压用于急性高容量血液稀释(AHH)后的颅内动脉瘤夹闭术病人,可降低脑氧代谢率,增强脑组织对缺氧的耐受性,比硝酸甘油控制性降压更具优越性。该论文发表在《中国微侵袭神经外科杂志》[2012,17(3):100-103]。   该研究收集了30例颅内动脉瘤夹闭术病人,并随机等分为硝酸甘油组和瑞芬太尼组。手术开始时以15~20&

  南昌大学第一附属医院张学康、曾而明等发表的一项研究表明,瑞芬太尼控制性降压用于急性高容量血液稀释(AHH)后的颅内动脉瘤夹闭术病人,可降低脑氧代谢率,增强脑组织对缺氧的耐受性,比硝酸甘油控制性降压更具优越性。该论文发表在《中国微侵袭神经外科杂志》[2012,17(3):100-103]。

  该研究收集了30例颅内动脉瘤夹闭术病人,并随机等分为硝酸甘油组和瑞芬太尼组。手术开始时以15~20 ml/(kg•h) 的速率输入4%琥珀酰明胶,使红细胞比容稀释为25%~32%。剪开硬脑膜后,分别泵入硝酸甘油和瑞芬太尼控制性降压,使平均动脉压 (MAP) 维持在60~65 mmHg。分别于降压前 (T1)、降压后30 min (T2)、动脉瘤夹闭后5 min (T3) 抽取颈内静脉球部血和桡动脉血作血气分析,比较两组对脑氧代谢的影响。

  结果是,血流动力学变化:与同组内T1比较,两组T2、T3的MAP和心率差异均有统计学意义 (P <0.01);两组同时间点MAP比较差异无统计学意义,心率差异有统计学意义 (P <0.01)。脑氧代谢的变化:与同组内T1比较,瑞芬太尼组T2、T3的静脉血氧饱和度 (SjvO2) 和颈内静脉氧含量 (CjvO2) 明显升高,动脉-颈内静脉球部血氧差 [D(a-jv)O2] 和氧摄取率 (ERO2) 明显降低 (P <0.01);两组同时间点 (T2、T3) 比较,SjvO2、CjvO2、D(a-jv)O2、ERO2差异均有统计学意义 (P <0.01)。
    

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1990478, encodeId=0d9b19904e823, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309320, encodeId=0ff1130932083, content=<a href='/topic/show?id=9faae35400d' target=_blank style='color:#2F92EE;'>#硝酸甘油#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73540, encryptionId=9faae35400d, topicName=硝酸甘油)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384798, encodeId=f3c31384e98b2, content=<a href='/topic/show?id=93918690e81' target=_blank style='color:#2F92EE;'>#芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86907, encryptionId=93918690e81, topicName=芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405253, encodeId=3a321405253eb, content=<a href='/topic/show?id=568068e40fa' target=_blank style='color:#2F92EE;'>#瑞芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68740, encryptionId=568068e40fa, topicName=瑞芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2a92531888, createdName=qidongfanjian, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417615, encodeId=1312141e61588, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80351, encryptionId=aada80351ae, topicName=耐受性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43843300457, createdName=Smile2681, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592035, encodeId=4b5e159203545, content=<a href='/topic/show?id=c3a68498683' target=_blank style='color:#2F92EE;'>#脑组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84986, encryptionId=c3a68498683, topicName=脑组织)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=819d18073578, createdName=yahu, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1990478, encodeId=0d9b19904e823, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309320, encodeId=0ff1130932083, content=<a href='/topic/show?id=9faae35400d' target=_blank style='color:#2F92EE;'>#硝酸甘油#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73540, encryptionId=9faae35400d, topicName=硝酸甘油)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384798, encodeId=f3c31384e98b2, content=<a href='/topic/show?id=93918690e81' target=_blank style='color:#2F92EE;'>#芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86907, encryptionId=93918690e81, topicName=芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405253, encodeId=3a321405253eb, content=<a href='/topic/show?id=568068e40fa' target=_blank style='color:#2F92EE;'>#瑞芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68740, encryptionId=568068e40fa, topicName=瑞芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2a92531888, createdName=qidongfanjian, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417615, encodeId=1312141e61588, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80351, encryptionId=aada80351ae, topicName=耐受性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43843300457, createdName=Smile2681, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592035, encodeId=4b5e159203545, content=<a href='/topic/show?id=c3a68498683' target=_blank style='color:#2F92EE;'>#脑组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84986, encryptionId=c3a68498683, topicName=脑组织)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=819d18073578, createdName=yahu, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1990478, encodeId=0d9b19904e823, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309320, encodeId=0ff1130932083, content=<a href='/topic/show?id=9faae35400d' target=_blank style='color:#2F92EE;'>#硝酸甘油#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73540, encryptionId=9faae35400d, topicName=硝酸甘油)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384798, encodeId=f3c31384e98b2, content=<a href='/topic/show?id=93918690e81' target=_blank style='color:#2F92EE;'>#芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86907, encryptionId=93918690e81, topicName=芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405253, encodeId=3a321405253eb, content=<a href='/topic/show?id=568068e40fa' target=_blank style='color:#2F92EE;'>#瑞芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68740, encryptionId=568068e40fa, topicName=瑞芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2a92531888, createdName=qidongfanjian, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417615, encodeId=1312141e61588, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80351, encryptionId=aada80351ae, topicName=耐受性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43843300457, createdName=Smile2681, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592035, encodeId=4b5e159203545, content=<a href='/topic/show?id=c3a68498683' target=_blank style='color:#2F92EE;'>#脑组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84986, encryptionId=c3a68498683, topicName=脑组织)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=819d18073578, createdName=yahu, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-04-15 xue8602
  4. [GetPortalCommentsPageByObjectIdResponse(id=1990478, encodeId=0d9b19904e823, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309320, encodeId=0ff1130932083, content=<a href='/topic/show?id=9faae35400d' target=_blank style='color:#2F92EE;'>#硝酸甘油#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73540, encryptionId=9faae35400d, topicName=硝酸甘油)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384798, encodeId=f3c31384e98b2, content=<a href='/topic/show?id=93918690e81' target=_blank style='color:#2F92EE;'>#芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86907, encryptionId=93918690e81, topicName=芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405253, encodeId=3a321405253eb, content=<a href='/topic/show?id=568068e40fa' target=_blank style='color:#2F92EE;'>#瑞芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68740, encryptionId=568068e40fa, topicName=瑞芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2a92531888, createdName=qidongfanjian, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417615, encodeId=1312141e61588, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80351, encryptionId=aada80351ae, topicName=耐受性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43843300457, createdName=Smile2681, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592035, encodeId=4b5e159203545, content=<a href='/topic/show?id=c3a68498683' target=_blank style='color:#2F92EE;'>#脑组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84986, encryptionId=c3a68498683, topicName=脑组织)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=819d18073578, createdName=yahu, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1990478, encodeId=0d9b19904e823, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309320, encodeId=0ff1130932083, content=<a href='/topic/show?id=9faae35400d' target=_blank style='color:#2F92EE;'>#硝酸甘油#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73540, encryptionId=9faae35400d, topicName=硝酸甘油)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384798, encodeId=f3c31384e98b2, content=<a href='/topic/show?id=93918690e81' target=_blank style='color:#2F92EE;'>#芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86907, encryptionId=93918690e81, topicName=芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405253, encodeId=3a321405253eb, content=<a href='/topic/show?id=568068e40fa' target=_blank style='color:#2F92EE;'>#瑞芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68740, encryptionId=568068e40fa, topicName=瑞芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2a92531888, createdName=qidongfanjian, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417615, encodeId=1312141e61588, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80351, encryptionId=aada80351ae, topicName=耐受性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43843300457, createdName=Smile2681, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592035, encodeId=4b5e159203545, content=<a href='/topic/show?id=c3a68498683' target=_blank style='color:#2F92EE;'>#脑组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84986, encryptionId=c3a68498683, topicName=脑组织)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=819d18073578, createdName=yahu, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1990478, encodeId=0d9b19904e823, content=<a href='/topic/show?id=26e2e7723a1' target=_blank style='color:#2F92EE;'>#组织缺氧#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=77723, encryptionId=26e2e7723a1, topicName=组织缺氧)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=2c25323, createdName=jambiya, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1309320, encodeId=0ff1130932083, content=<a href='/topic/show?id=9faae35400d' target=_blank style='color:#2F92EE;'>#硝酸甘油#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=48, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=73540, encryptionId=9faae35400d, topicName=硝酸甘油)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=hb2008ye, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1384798, encodeId=f3c31384e98b2, content=<a href='/topic/show?id=93918690e81' target=_blank style='color:#2F92EE;'>#芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=86907, encryptionId=93918690e81, topicName=芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d139492, createdName=xue8602, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1405253, encodeId=3a321405253eb, content=<a href='/topic/show?id=568068e40fa' target=_blank style='color:#2F92EE;'>#瑞芬太尼#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=30, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=68740, encryptionId=568068e40fa, topicName=瑞芬太尼)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=d2a92531888, createdName=qidongfanjian, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1417615, encodeId=1312141e61588, content=<a href='/topic/show?id=aada80351ae' target=_blank style='color:#2F92EE;'>#耐受性#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80351, encryptionId=aada80351ae, topicName=耐受性)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=43843300457, createdName=Smile2681, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1592035, encodeId=4b5e159203545, content=<a href='/topic/show?id=c3a68498683' target=_blank style='color:#2F92EE;'>#脑组织#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=84986, encryptionId=c3a68498683, topicName=脑组织)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=819d18073578, createdName=yahu, createdTime=Sun Apr 15 15:30:00 CST 2012, time=2012-04-15, status=1, ipAttribution=)]
    2012-04-15 yahu